|
HS Code |
181901 |
As an accredited 4-Bromo-2-Iodo-1-(Benzenesulfonyl)-1H-Pyrrolo[2,3-B]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-2-Iodo-1-(Benzenesulfonyl)-1H-Pyrrolo[2,3-B]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemical research feels a lot like a treasure hunt—sometimes you’re digging for something valuable you’re not even sure exists. Working in the lab often means not only hunting for new compounds but wrestling with the challenge of making complex molecules more accessible. In recent years, one compound—4-Bromo-2-Iodo-1-(Benzenesulfonyl)-1H-Pyrrolo[2,3-B]Pyridine—has caught the eye of more than a few researchers. Its structure stands out, bearing both a bromine and an iodine atom along with a benzenesulfonyl group. This isn't just adding to a catalog; it marks a significant step in opening up new synthetic possibilities without the outdated hurdles that held chemists back two decades ago.
At first glance, the core of this molecule might seem overwhelming—a fused pyrrolopyridine backbone already draws a crowd in medicinal chemistry. By adding both a bromine and an iodine atom, chemists have built in flexibility for cross-coupling reactions, which matters most if you’re charting new ground in heterocyclic chemistry. The benzenesulfonyl group isn’t just cosmetic either; it influences both solubility and the behavior of the molecule during tricky transformations. People who run late-night rounds with NMR and HPLC know features like these mean you spend less time troubleshooting and more time building out pathways toward new drug candidates.
Let’s break it down further. Anyone in pharmaceutical discovery staring down a dry pipeline or a slow SAR campaign gets restless at the sight of rigid, old-school reagents. Years ago, I remember scouring catalogs and ending up frustrated by missing halogenated pyridines that only covered lazy substitutions, never offering the one-two punch that a bromo-iodo setup provides. That sort of limitation shackled my creativity and, honestly, wasted time. Now, with access to this dual-halogenated scaffold, med chem teams are jumping a traditional hurdle with ease, running both Suzuki and Sonogashira couplings on the same backbone—no more hand-waving about route flexibility.
Synthetic chemists aren’t the only ones taking notice. In academia, students pushing for new routes or trying to teach selectivity have a live one on their bench. No more chalkboard theory; this kind of chemical lets people cut their teeth on real reaction planning. Also, people developing new ligands, probes, or even nano-materials notice the compound’s reactivity and the way that sulfonyl group tunes electronics and solubility. In short, this molecule isn’t another paint-by-numbers reagent; it challenges users to push boundaries but doesn't trip them up with unreasonable obstacles.
Some say every new pyrrolo[2,3-b]pyridine derivative is just another card in the deck. I disagree. This one leans into the value of selectivity—sometimes you end up with cleaner reactions, genuine advances in yield, and fewer headaches due to byproducts. Adding the benzenesulfonyl group tunes pKa and the way the compound holds up under different conditions. From personal experience, I recall projects stalling out because an intermediate lacked just the right balance between stability and reactivity. 4-Bromo-2-Iodo-1-(Benzenesulfonyl)-1H-Pyrrolo[2,3-B]Pyridine stands out by avoiding both the glass-jawed sensitivity of some iodo compounds and the sullen stubbornness seen in mono-halogenated scaffolds.
People who have spent time purifying gummed-up reactions know the empty promise of “>98% purity” on a certificate. Real quality shows itself when a reagent doesn’t leave behind pesky halide salts or mystery side products. Chemists value not just purity, but consistency and reliable handling. 4-Bromo-2-Iodo-1-(Benzenesulfonyl)-1H-Pyrrolo[2,3-B]Pyridine typically arrives as a pale powder, stable under normal bench conditions, and doesn’t bite back with wild volatility or noxious fumes. HPLC and NMR confirmation come routine, which means you aren’t flying blind and can trust your input before you build out a reaction scheme. Labs working under tight timelines can count on scales anywhere from a few milligrams up to hundreds of grams, which reflects a welcome shift from the awkward minimum order sizes that haunted previous generations of custom reagents.
From sample to storage, this compound doesn’t demand exotic protocols. Standard glassware, argon gloveboxes only if you’re truly at the edges, and packaging that stands up to a bit of manhandling during receipt and transfer. Safety data confirms low volatility and moderate hazard—the kind chemists expect from sulfonyl and halogen-bearing rings, not the kind that sends the lab running for respirators. All in all, specs reflect the reality of synthetic work, not some marketing gloss or the theoretical whims of a spreadsheet.
Think back to classic pyrrolopyridine methods. Maybe you’ve worked with systems where you could swap in a single halogen, usually bromine, and then spent weeks banging your head trying to find an orthogonal functional handle for downstream modification. The lack of dual-halogenation turned every new route into a negotiation—what to protect, what to deprotect, whether one coupling would knock out the other group, and often, why one pathway worked twice as well (or half as well) as the paper promised.
4-Bromo-2-Iodo-1-(Benzenesulfonyl)-1H-Pyrrolo[2,3-B]Pyridine shrugs off that old dogma. Direct, position-selective halogenation opens the door for iterative couplings using modern palladium catalysts or even silver and copper systems, reducing wasted time and boosting the pace of real discovery. The benzenesulfonyl group, tucked away on the nitrogen, stands out compared to methyl, benzyl, or even nitro groups—offering just the right mix of electron-donating and withdrawing character so you don’t end up with unpredictable or finicky transformation outcomes.
Let’s get specific about where this chemical matters. In drug discovery, flexibility counts. Teams hammering away at kinase inhibitors, CNS-active agents, or antiviral scaffolds now have a tool that doesn’t back them into a synthetic corner. The core skeleton, marked by its fused heterocycle, shows up in an array of biologically active compounds—meaning that every new substitution can unlock as-yet-unexplored drug-like space.
On the material science horizon, the bromine and iodine tags invite researchers to build new polymers, dyes, light-emitting diodes, and even receptors with tailored optoelectronic properties. Real innovation happens through these subtle tweaks, not just brute-forcing larger and larger scaffold assemblies.
Even academic labs, routinely hammered by budget constraints and grant timelines, now enjoy a reliable way to explore more sophisticated substitution patterns without trading off safety or bench-scale practicality. This may sound mundane, but speaking from years trying to wring extra value out of every order, that reliability in supply and consistency trumps flash or theoretical performance claims any day.
For too long, organic chemistry has suffered from the curse of irreproducible published methods and supply chain interruptions. Too often, new researchers spend months grinding out a tricky synthesis, only to discover the critical intermediate came from a supplier with erratic documentation or inconsistent lots. That misses the point of real collaboration and honest scientific progress. This compound, owing to increased interest and more robust routes, now arrives with solid documentation, batch control, and trustworthy lot testing. That means less wasted time and more honest comparison between research groups, which benefits everyone trying to build on each other’s work.
Scaling up can scare off even seasoned chemists. If you’ve ever needed to jump from milligram to gram quantities, you’ve likely felt the pain of de-risking safety, cost, and yield all at once. The well-documented handling characteristics of this molecule let project managers and bench scientists build credible Gantt charts with fewer last-minute surprises. Team leads can move past bottlenecks like custom synthesis delays or purity lapses and focus resources on experiments that actually push science forward rather than debugging a wayward batch or hunting down tainted starting material.
Many compounds jostle for attention with little to show beyond a new sticker price. This one brings real leverage. Its two halogens, neither too labile nor too stubborn, let chemists run sequential reactions, tagging the ring at one site, then the other, with selective catalysts. Ever tried swapping an iodine for something exotic while leaving a bromine untouched? Those who have know just how rare this kind of control is. The benzenesulfonyl group offers extra options for downstream modification without gumming up solubility, which often plagues high-molecular-weight rings.
Previous attempts at these hybrid halogenated pyrrolopyridines typically ran aground due to unstable linkages or awkwardly protected nitrogens that choked off reactivity. Replacing those with the strong, well-understood benzenesulfonyl group cracks open robust, repeatable transformations—worth its weight in gold for anyone mapping out a library of analogs.
In the real world, chemists and project leaders report better recovery after workup and more reliable reaction scales than older cousins in the chemical family. This translates to less messy chromatography and faster analytics—practical, observable benefits, not just paper stats.
My own career has spanned ten years across academic and industry labs. Over that time, I watched colleagues struggle with ill-timed supply issues, ambiguous purity readings, and frustrating ambiguity in reactivity. Modern scientific work now demands better: well-documented sourcing, consistent supply, robust certificates of analysis, and, above all, the open exchange of technical support and troubleshooting. Suppliers stepping up in these ways signal real progress. This compound’s presence in multiple catalogs, its tested documentation, and the reliability of its supply chain mark a maturing industry that sees research teams as partners, not just customers to be upcharged.
No chemical is a silver bullet. Dual-halogenated systems still require sharp attention to side reactions, especially at higher temperature or when paired with reactive metals. Those exploring new reactions do well to remember that the presence of both bromine and iodine can sometimes lead to mixed coupling products—if the conditions slip, you might see selectivity drift. Regular, careful reaction monitoring and full analytical workups are still part of the game, as with any advanced starting material.
Supply chain stability earned over the last few years improves confidence, yet any rare building block can fall victim to shipping delays, regulatory snags, or changes in precursor availability. Sourcing from suppliers that provide regular documentation, who respond rapidly to queries, and offer transparent inventory updates can mitigate most issues. Teams planning for scale should always run small-scale pilots and request comprehensive documentation—if anything deviates, honest communication with the supply chain goes further than squeezing every last cent out of an order.
With access to scaffolds like 4-Bromo-2-Iodo-1-(Benzenesulfonyl)-1H-Pyrrolo[2,3-B]Pyridine, more research projects tackle chemical space previously written off as too risky, time-consuming, or outright unworkable. Teams can chart expanded SAR, explore subtle bioisosteric replacements in medicinal chemistry, or chase new optoelectronic materials. Each successful reaction run closes the gap between the hypothetical promise of fused heterocycles and their realized impact in pharmaceuticals, agrochemicals, and advanced materials.
Chemistry thrives on the honest reporting of setbacks as well as successes. By sharing best practices, unvarnished results, and relevant safety experiences, research communities can support better, more efficient science. Professional forums, open data sharing, and direct communication serve as engines for real progress. This compound, with its robust documentation and thoughtful design, underscores how a well-considered starting material doesn’t just fill a catalog slot—it actively shapes the trajectory of discovery.
The lesson for both experienced and new chemists: Chemistry isn’t just about the molecules on the page, but about the people using them. Reliable, thoughtfully engineered chemicals allow researchers to focus on what matters—testing hypotheses, building real knowledge, and driving progress in fields that matter to society. 4-Bromo-2-Iodo-1-(Benzenesulfonyl)-1H-Pyrrolo[2,3-B]Pyridine stands as more than a compound; it’s a real-world response to the demands of modern science, designed and delivered with both innovation and practicality in mind.